BUSINESS ANALYSIS DECADAL
: Endorex Corporation is a development stage bio- technology company involved in oral drug delivery and cancer therapy. The Company has developed two products which have undergone clinical trials. For the 3 months ended 3/31/00, the Company reported no revenues. Net loss applic. to Common fell 17% to $1.8M. Lower loss reflects reduced spending on oncology product development and the absence of amortization for financial advisory warrants.